Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 3201 - 3225 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
Gangliosides LMSP0601EU05
  • NeuAcalpha2-3Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262912 1792.023387 C85H153N3O36
Gangliosides LMSP0601GK05
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44263208 1792.023387 C85H153N3O36
Gangliosides LMSP0601GL05
  • NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44263216 1792.023387 C85H153N3O36
Gangliosides LMSP0601GS05
  • Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44263264 1792.023387 C85H153N3O36
Gangliosides LMSP0601GW05
  • NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44263296 1792.023387 C85H153N3O36
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AG07
  • Bleb(d18:1/24:1(15Z))
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260666 1791.028138 C86H154N2O36
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CY07
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261562 1791.028138 C86H154N2O36
Gangliosides LMSP0601AL03
  • GT3(d18:1/20:0)
  • NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262054 1790.966601 C83H146N4O37
Gangliosides LMSP0601AB07
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • SSEA-4 antigen(d18:1/24:1(15Z))
44261978 1790.007737 C85H151N3O36
Gangliosides LMSP0601AI07
  • NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • SSEA-4 positional isomer(d18:1/24:1(15Z))
44262034 1790.007737 C85H151N3O36
Gangliosides LMSP0601CN07
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262474 1790.007737 C85H151N3O36
Gangliosides LMSP0601DV07
  • NeuAcalpha2-3Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262722 1790.007737 C85H151N3O36
Gangliosides LMSP0601EU07
  • NeuAcalpha2-3Galbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262914 1790.007737 C85H151N3O36
Gangliosides LMSP0601GK07
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44263210 1790.007737 C85H151N3O36
Gangliosides LMSP0601GL07
  • NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44263218 1790.007737 C85H151N3O36
Gangliosides LMSP0601GS07
  • Galalpha1-3(NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44263266 1790.007737 C85H151N3O36
Gangliosides LMSP0601GW07
  • NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44263298 1790.007737 C85H151N3O36
Gangliosides LMSP0601AN06
  • GD2(d18:1/26:0)
  • GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262073 1787.044456 C86H154N4O34
Gangliosides LMSP0601AN08
  • GD2(d18:1/26:1(17Z))
  • GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262075 1785.028806 C86H152N4O34
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AW05
  • Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260344 1784.007069 C84H153NO38
Gangliosides LMSP0601DE03
  • KDNGD1a(d18:1/20:0)
  • KDNalpha2-3Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262590 1782.950283 C82H146N2O39
Gangliosides LMSP0601DI03
  • KDN GD1a 2(d18:1/20:0)
  • KDNalpha2-3Galbeta1-3(KDNalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262622 1782.950283 C82H146N2O39
Diacylglycerophosphoinositolglycans LMGP15010243
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1,2-dihexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(16:0/16:0)
126457611 1782.842783 C77H139O43P
Diacylglycerophosphoinositolglycans LMGP15010254
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(18:0/14:0)
126457622 1782.842783 C77H139O43P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AW07
  • Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260346 1781.991419 C84H151NO38

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024